<?xml version="1.0" encoding="UTF-8"?>
<p>Also taken into consideration is the biology of the disease model(s) and how a compound would appropriately interfere with this disease. In animal efficacy studies, we have shown that ST-246 can be given prophylactically, post-exposure prophylactically, and therapeutically to prevent and/or treat orthopoxvirus diseases (
 <xref rid="bib1" ref-type="bibr">Quenelle et al., 2007</xref>, 
 <xref rid="bib2" ref-type="bibr">Sbrana et al., 2007</xref>) (Huggins et al., 20th ICAR, Palm Springs, 2007). Therefore, with ST-246, one could initiate treatment with the drug and then follow this with a vaccination campaign until the threat is gone.
</p>
